:

What is the new FDA approved drug for osteoporosis? Understanding Biosimilars in 2024 and 2025

As of September 2025, several biosimilars for the reference drug denosumab have received FDA approval, expanding the treatment options for patients with osteoporosis. Many patients wonder, "What is the new FDA approved drug for osteoporosis?", and recent approvals include Jubbonti (denosumab-bbdz), approved in March 2024, and Bosaya (denosumab-kyqq), approved in September 2025.